Which specific CSF molecular components are essential for maintaining disease-relevant α-synuclein fibril structure?

Hypothesis 1: Specific CSF lipoprotein components, especially ApoE- and clusterin-rich particles, bind alpha-synuclein fibril surfaces and stabilize disease-relevant polymorphs by modulating surface hydration and lateral packing. Test: reconstitute fibrils with purified ApoE or CLU fractions and compare cryo-EM class distributions and seeding potency.

Hypothesis 2: Extracellular vesicle membranes and ganglioside-rich lipid fragments in CSF provide the structural cofactor that preserves a brain-derived fibril conformation outside cells. This predicts that vesicle depletion or ganglioside digestion will shift fibril morphology and reduce conformational fidelity. Test: EV fractionation, lipidomics, and serial seeding with morphology readouts.

Hypothesis 3: Sulfated glycans and low-abundance metal-binding proteins in CSF act as molecular braces that stabilize a subset of fibril polymorphs through electrostatic cross-bridging. Test: glycosaminoglycan depletion, divalent cation chelation, and mass spectrometry of fibril-bound CSF proteins.

Hypothesis 1 is biologically plausible and experimentally tractable, but CSF lipoproteins are heterogeneous and disease state may matter as much as component identity. Stabilization could reflect nonspecific protein crowding unless purified fractions reproduce the effect with dose dependence.

Hypothesis 2 may capture something important because alpha-syn fibrils interact strongly with lipid surfaces, yet EV preparations are notoriously mixed. If EV depletion changes seeding simply by removing generic protein or lipid mass, then the mechanism remains underspecified.

Hypothesis 3 is the most open-ended. Electrostatic or metal-mediated stabilization is easy to invoke and hard to pin to a specific molecule; without binding proteomics and depletion-rescue experiments it risks becoming a residual bucket for unexplained effects.

For translation and biomarker development, the best program is biochemical fractionation of patient CSF coupled to structural and seeding assays. The field does not need another bulk-correlative proteomics pass first; it needs causal fraction-addback experiments that identify which fractions preserve the fibril polymorph and which do not.

Lipoprotein and EV models rank highest because they provide concrete, purifiable material and a direct route to structural validation by cryo-EM, proteomics, and serial seeding. If a stabilizing cofactor can be isolated, it becomes both a mechanistic clue to in vivo templating and a potential biomarker axis for synucleinopathy subtype stratification.